Literature DB >> 6850989

Phosphorylation of cytochrome-P-450-dependent monooxygenase components.

W Pyerin, C R Wolf, V Kinzel, D Kübler, F Oesch.   

Abstract

Most chemical carcinogens require activation by polysubstrate monooxygenase. The phosphorylation of essential components of this cytochrome P-450 monooxygenase system, isolated from rabbit liver microsomes, cytochrome P-450 (LM2) and cytochrome reductase, was tested using two different protein kinases. One of the kinases, a cyclic AMP-independent phosvitin kinase (kinase P), was inactive in all systems tested. However, the catalytic subunit of a cyclic AMP-dependent protein kinase (kinase C) catalyzed phosphoryl group transfer to both proteins, but to different extents. Cytochrome P-450 was phosphorylated when added as sole component and also when in the presence of P-450 reductase and phosphatidylcholine. In contrast, the weak phosphorylation of P-450 reductase was reduced considerably in a complete reconstituted system containing P-450 and phosphatidylcholine. The inclusion of kinase P did not alter these results which excludes the possibility that these kinases participate in a sequential phosphorylation mechanism. The monooxygenase constituents themselves were without kinase activity. When hepatic microsomes were isolated in presence of the phosphatase inhibitor sodium fluoride no significant change in monooxygenase (7-ethoxycoumarin O-deethylation) activity was observed, whilst after preincubation with either acid or alkaline phosphatase a significant reduction in monooxygenase activity was measured. Thus, cytochrome P-450 (LM2) is phosphorylatable by protein kinase C and the catalytic activity of polysubstrate monooxygenase decreases after preincubation of microsomes with phosphatases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6850989     DOI: 10.1093/carcin/4.5.573

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

Review 1.  Phosphorylation of cytochrome P450 isoenzymes in intact hepatocytes and its importance for their function in metabolic processes.

Authors:  B Oesch-Bartlomowicz; F Oesch
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Posttranslational modifications of the cytochrome P-450 monooxygenase system.

Authors:  W Pyerin; F Horn; H Taniguchi
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Multisite phosphorylation of human liver cytochrome P450 3A4 enhances Its gp78- and CHIP-mediated ubiquitination: a pivotal role of its Ser-478 residue in the gp78-catalyzed reaction.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Yi Liu; Ranjit K Thirumaran; Relly Brandman; Erin G Schuetz; Alma L Burlingame; Maria Almira Correia
Journal:  Mol Cell Proteomics       Date:  2011-11-17       Impact factor: 5.911

Review 4.  Hepatic cytochrome P450 ubiquitination: conformational phosphodegrons for E2/E3 recognition?

Authors:  Maria Almira Correia; YongQiang Wang; Sung-Mi Kim; Shenheng Guan
Journal:  IUBMB Life       Date:  2014-02-03       Impact factor: 3.885

5.  Immobilized E. coli alkaline phosphatase. Its properties, stability, and utility in studying the dephosphorylation of proteins.

Authors:  K Basheeruddin; V Rothman; S Margolis
Journal:  Appl Biochem Biotechnol       Date:  1985-04       Impact factor: 2.926

6.  A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation.

Authors:  Yongqiang Wang; Mingxiang Liao; Nicholas Hoe; Poulomi Acharya; Changhui Deng; Andrew N Krutchinsky; Maria Almira Correia
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

7.  Phosphorylation of hepatic phenobarbital-inducible cytochrome P-450.

Authors:  W Pyerin; H Taniguchi
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

8.  Mechanism-based predictions of interactions.

Authors:  F Oesch; B Oesch-Bartlomowicz; J Arens; F Fähndrich; E Vogel; T Friedberg; H Glatt
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.